KalVista Pharmaceuticals, Inc. (KALV) Stock Ticker
KALV right now
Market factors today
Unlock the full KALV picture
About KalVista Pharmaceuticals, Inc.
KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: Sebetralstat for HAE and Factor XIIa. The company was founded by T. Andrew Crockett, Edward P. Feener, and Lloyd Paul Aiello on March 26, 2004 and is headquartered in Framingham, MA.
KALV stock facts
| Ticker symbol | KALV |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $1.4B |
| CEO | Benjamin L. Palleiko |
| Employees | 275 |
| Headquarters | Framingham, MA, US |
| IPO date | 2015-04-09 |
| Website | www.kalvista.com |
What you can see for KALV on Tickr
Live KALV price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the KALV report.
Rankings
FAQ
What is the ticker symbol for KalVista Pharmaceuticals, Inc.?
The ticker symbol for KalVista Pharmaceuticals, Inc. is KALV, listed on the NASDAQ.
What is KALV?
KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: Sebetralstat for HAE and Factor XIIa. The company was founded by T. Andrew…